We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

130 hedge funds and large institutions have $648M invested in Arena Pharmaceuticals Inc in 2015 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 47 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 12

43% more call options, than puts

Call options by funds: $9.68M | Put options by funds: $6.75M

7% more funds holding

Funds holding: 122 → 130 (+8)

6% more capital invested

Capital invested by funds: $611M → $648M (+$37.4M)

26% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 47

Holders
130
Holders Change
+8
Holders Change %
+6.56%
% of All Funds
3.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
35
Reduced
47
Closed
12
Calls
$9.68M
Puts
$6.75M
Net Calls
+$2.92M
Net Calls Change
+$3.71M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$7.64M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.11M
3
OAM
Oxford Asset Management
United Kingdom
+$4.2M
4
Renaissance Technologies
Renaissance Technologies
New York
+$3.22M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.24M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$9.74M
2
Millennium Management
Millennium Management
New York
-$7.12M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$3.87M
4
TA
Teachers Advisors
New York
-$2.47M
5
BIT
BlackRock Institutional Trust
California
-$1.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
126
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$707 -$28.1K -647 -4%
FCCM
127
First City Capital Management
Georgia
$464 – – –
N
128
Nuveen
North Carolina
$83 -$3.38K -78 -4%
VFA
129
Virtus Fund Advisers
Connecticut
– -$684K -15,650 Closed
Janney Montgomery Scott
130
Janney Montgomery Scott
Pennsylvania
– -$490K -11,220 Closed
BNP Paribas Asset Management
131
BNP Paribas Asset Management
France
– -$295K -6,745 Closed
TI
132
Trexquant Investment
Connecticut
– -$205K -4,703 Closed
Jane Street
133
Jane Street
New York
– -$191K -4,396 Closed
TRCT
134
Tower Research Capital (TRC)
New York
– -$158K -3,620 Closed
JG
135
Jefferies Group
New York
– -$147K -3,360 Closed
Tudor Investment Corp
136
Tudor Investment Corp
Connecticut
– -$69K -1,581 Closed
ID
137
Integral Derivatives
New York
– -$47K -1,071 Closed
LIA
138
LS Investment Advisors
Michigan
– -$42K -970 Closed
HNB
139
Huntington National Bank
Ohio
– -$11K -259 Closed
WA
140
Winfield Associates
Ohio
– -$9K -200 Closed
2 3 4 5
6

ARNA Hedge Fund Activity: Q2 2015 in Review

130 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2015, worth a combined $648M — up 6.1% from $611M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new ARNA positions and 12 closed out — a net gain of 8 holders — while 35 added to existing stakes and 47 trimmed.

The largest buyer was State Street, adding an estimated $7.64M. The largest seller was Deerfield Management, cutting an estimated $9.74M.

  • 130 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2015, up from 122 in Q1 2015.
  • Funds reported $648M of Arena Pharmaceuticals Inc stock for Q2 2015, up 6.1% quarter-over-quarter.
  • 20 funds opened new Arena Pharmaceuticals Inc positions in Q2 2015 and 12 closed out, a net change of +8 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2015 was State Street, an estimated $7.64M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2015 was Deerfield Management, an estimated $9.74M sold.

Based on aggregated 13F filings for Q2 2015.